Continuous variables, mean ± SD
|
Age (year)
|
55.1 ± 11.0
|
58.4 ± 11.1
|
53.5 ± 10.8
|
56.8 ± 11.1
|
53.6 ± 10.9
|
56.8 ± 10.9
|
51.9 ± 10.7
|
54.9 ± 10.7
|
53.1 ± 11.2
|
56.6 ± 11.2
|
53.6 ± 11.0
|
56.8 ± 11.0
|
BMI (kg/m2)
|
29.9 ± 4.5
|
27.7 ± 4.4
|
29.7 ± 5.0
|
28.7 ± 4.8
|
29.0 ± 4.0
|
29.1 ± 4.1
|
28.0 ± 4.2
|
29.0 ± 4.5
|
27.9 ± 5.0
|
30.7 ± 5.4
|
28.9 ± 4.4
|
29.1 ± 4.6
|
SBP (mmHg)
|
134.4 ± 21.6
|
129.8 ± 20.2
|
135.5 ± 23.9
|
133.7 ± 22.7
|
132.7 ± 22.0
|
130.8 ± 21.0
|
130.7 ± 22.6
|
129.9 ± 22.3
|
128.9 ± 22.1
|
131.3 ± 23.3
|
132.4 ± 22.3
|
131.0 ± 21.6
|
DBP (mmHg)
|
84.0 ± 12.1
|
78.4 ± 11.7
|
83.0 ± 11.6
|
78.9 ± 11.5
|
82.3 ± 11.6
|
79.4 ± 10.5
|
81.6 ± 10.1
|
78.9 ± 9.2
|
80.6 ± 11.5
|
78.3 ± 11.7
|
82.3 ± 11.5
|
79.0 ± 10.9
|
FPG (mmol/L)a
|
9.1 ± 3.1
|
9.8 ± 4.2
|
9.1 ± 3.4
|
9.4 ± 3.8
|
8.6 ± 3.2
|
8.6 ± 3.2
|
7.5 ± 3.2
|
7.5 ± 2.5
|
8.2 ± 3.9
|
7.8 ± 2.9
|
8.6 ± 3.4
|
8.7 ± 3.4
|
Total cholesterol (mmol/L)a
|
6.2 ± 1.4
|
5.5 ± 1.2
|
5.8 ± 1.1
|
5.4 ± 1.0
|
5.9 ± 1.3
|
5.4 ± 1.2
|
5.8 ± 1.0
|
5.5 ± 0.9
|
5.8 ± 1.3
|
5.4 ± 1.2
|
5.9 ± 1.3
|
5.4 ± 1.1
|
e-GFR (mL/min/1.73 m2)
|
63.2 ± 10.4
|
66.4 ± 9.5
|
67.6 ± 11.6
|
69.3 ± 12.1
|
65.6 ± 10.7
|
69.4 ± 13.0
|
65.2 ± 11.1
|
71.4 ± 12.6
|
66.9 ± 12.5
|
68.2 ± 13.2
|
65.6 ± 11.2
|
68.9 ± 12.5
|
Categorical variables, number (%)
|
Educational level, years
|
< 6
|
83 (67.5)
|
78 (63.4)
|
44 (50.6)
|
47 (54.7)
|
219 (62.9)
|
217 (62.5)
|
41 (56.2)
|
42 (57.5)
|
78 (59.1)
|
79 (59.8)
|
465 (60.9)
|
463 (60.8)
|
6–12
|
29 (23.6)
|
35 (28.5)
|
35 (40.2)
|
30 (34.9)
|
106 (30.5)
|
106 (30.5)
|
27 (37.0)
|
26 (35.6)
|
49 (37.1)
|
48 (36.4)
|
246 (32.2)
|
245 (32.2)
|
> 12
|
11 (8.9)
|
10 (8.1)
|
8 (9.2)
|
9 (10.5)
|
23 (6.6)
|
24 (6.9)
|
5 (6.8)
|
5 (6.8)
|
5 (3.8)
|
5 (3.8)
|
52 (6.8)
|
53 (7.0)
|
Current smoker
|
7 (5.7)
|
6 (4.9)
|
11 (12.6)
|
11 (12.6)
|
34 (9.8)
|
33 (9.5)
|
10 (14.1)
|
9 (12.3)
|
13 (9.9)
|
10 (7.6)
|
75 (9.9)
|
69 (9.0)
|
Family history of premature CVD, yes
|
28 (22.8)
|
32 (26.0)
|
17 (19.5)
|
22 (25.3)
|
64 (18.4)
|
79 (22.7)
|
16 (21.9)
|
23 (31.5)
|
19 (14.4)
|
25 (18.9)
|
144 (18.9)
|
181 (23.7)
|
GLD use, yes
|
47 (38.2)
|
51 (41.5)
|
27 (31.0)
|
40 (46.0)
|
104 (29.9)
|
149 (42.8)
|
22 (30.1)
|
26 (35.6)
|
36 (27.3)
|
59 (44.7)
|
236 (30.9)
|
325 (42.6)
|
Anti-hypertensive drug use, yes
|
29 (23.6)
|
31 (25.2)
|
22 (25.3)
|
23 (26.4)
|
56 (16.1)
|
67 (19.3)
|
9 (12.3)
|
11 (15.1)
|
27 (20.5)
|
30 (22.7)
|
143 (18.7)
|
162 (21.2)
|
Lipid-lowering drug use, yes
|
14 (11.4)
|
13 (10.6)
|
11 (12.6)
|
16 (18.4)
|
36 (10.3)
|
40 (11.5)
|
5 (6.8)
|
4 (5.5)
|
7 (5.3)
|
13 (9.8)
|
73 (9.6)
|
86 (11.3)
|